Top Markets
Coin of the day
ZyVersa Therapeutics, Inc. ZyVersa Therapeutics, Inc.

ZyVersa Therapeutics, Inc.

ZVSA
Rangering i aksjer #38792
ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical... ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, dedicated to advancing and commercializing therapies for renal (kidney) and inflammatory disorders. The company's pipeline prominently features VAR 200, a cholesterol efflux modulator aimed at addressing kidney diseases such as focal segmental glomerulosclerosis, Alport syndrome, and diabetic kidney disease. Furthermore, ZyVersa is advancing IC 100, a pioneering inflammasome ASC inhibitor positioned to tackle a wide array of inflammatory conditions. The company maintains its corporate headquarters in Weston, Florida.
Aksjekurs
$0.099
Markedsverdi
$801.50K
Endring (1 dag)
0.00%
Endring (1 år)
-34.44%
Land
US
Handel ZyVersa Therapeutics, Inc. (ZVSA)

Kategori

Historikk for aksjesplitt for ZyVersa Therapeutics, Inc. (ZVSA)
Aksjen ZyVersa Therapeutics, Inc. (symbol: ZVSA) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 14, 2026.
Én ZVSA-aksje kjøpt før Aug 14, 2026 tilsvarer i dag 0 ZVSA-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE